ICU Medical (ICUI) vs. Syneron Medical (ELOS) Financial Analysis

ICU Medical (NASDAQ: ICUI) and Syneron Medical (NASDAQ:ELOS) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership and risk.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for ICU Medical and Syneron Medical, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICU Medical 0 2 1 0 2.33
Syneron Medical 0 1 0 0 2.00

Syneron Medical has a consensus price target of $11.00, suggesting a potential upside of 0.00%. Given Syneron Medical’s higher probable upside, analysts plainly believe Syneron Medical is more favorable than ICU Medical.

Profitability

This table compares ICU Medical and Syneron Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ICU Medical 5.31% 8.42% 6.48%
Syneron Medical -1.09% -1.74% -1.30%

Institutional & Insider Ownership

76.9% of ICU Medical shares are held by institutional investors. Comparatively, 69.2% of Syneron Medical shares are held by institutional investors. 13.6% of ICU Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares ICU Medical and Syneron Medical’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
ICU Medical $1.29 billion 3.96 $68.64 million $5.52 45.85
Syneron Medical N/A N/A N/A N/A N/A

ICU Medical has higher revenue and earnings than Syneron Medical.

Volatility and Risk

ICU Medical has a beta of 0.36, indicating that its stock price is 64% less volatile than the S&P 500. Comparatively, Syneron Medical has a beta of 1.25, indicating that its stock price is 25% more volatile than the S&P 500.

Summary

ICU Medical beats Syneron Medical on 8 of the 10 factors compared between the two stocks.

About ICU Medical

ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein for use in hospitals and ambulatory clinics. The company's infusion therapy products include needlefree connector products, such as MicroClave and MicroClave Clear, Neutron, NanoClave, Clave, and SwabCap; custom infusion sets; and Tego needlefree hemodialysis connectors. It also provides critical care products that are used to monitor signs, as well as physiological functions of organ systems. The company's critical care products comprises hemodynamic monitoring systems and SafeSet closed blood sampling and conservation systems, as well as sensing catheters, Lopez Valve, and cables and accessories for hemodynamic monitoring. In addition, it offers a line of oncology products, which are used to prepare and deliver hazardous medications for use in chemotherapy, such as ChemoLock and ChemoClave closed system transfer devices and components, and Diana hazardous drug compounding systems. The company sells its products to medical product manufacturers, distributors, and end-users. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

About Syneron Medical

Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company’s aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. The Company’s products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, tattoo removal, rejuvenation of the skin’s appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and laser-assisted lipolysis.

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Tampa Bay Starting Relievers In Place of Starters
Tampa Bay Starting Relievers In Place of Starters
Teen Juan Soto Hits Home Run in First At-Bat
Teen Juan Soto Hits Home Run in First At-Bat
Ji-Man Choi Receives Another Chance in Milwaukee
Ji-Man Choi Receives Another Chance in Milwaukee
Marlins vs Dodgers sets a 10-year record in MGM sportsbooks
Marlins vs Dodgers sets a 10-year record in MGM sportsbooks
Strikeouts Once Again Plaguing Cubs
Strikeouts Once Again Plaguing Cubs
Atlanta Braves: A Mix of Young and Old
Atlanta Braves: A Mix of Young and Old


Leave a Reply

 
© 2006-2018 BBNS.